Fenofibrate to prevent amputation and reduce vascular complications in patients with diabetes: FENO-PREVENT
This nationwide population-based retrospective observational study suggests that fenofibrate can prevent LEA and PAD in patients with T2D who are on statin therapy.
Authors
- Eu Jeong Ku (ORCID: https://orcid.org/0000-0001-5533-4989)
- Hyuk‐Sang Kwon (ORCID: https://orcid.org/0000-0003-4026-4572)
- SeungHwan Lee (ORCID: https://orcid.org/0000-0002-1713-9194)
- Kyung‐Do Han (ORCID: https://orcid.org/0000-0003-2718-4308)
- Bongseong Kim
Institutions
- Seoul National University (KR)
- Soongsil University (KR)
- Seoul National University Hospital (KR)
- The Catholic University of Korea Yeouido St. Mary's Hospital (KR)
- The Catholic University of Korea Seoul St. Mary's Hospital (KR)
- Naver (South Korea) (KR)
- Catholic University of Korea (KR)
Publication Details
- Journal
- Cardiovascular Diabetology
- Published
- 2024-09-03
- DOI
- https://doi.org/10.1186/s12933-024-02422-9
- Citations
- 9
- Primary Topic
- Peripheral Artery Disease Management
- Type
- article
- Field-Weighted Citation Impact
- 5.15